Alagille syndrome (ALGS) is a rare genetic disorder that affects around one in every 30,000 live births. It results from...
Search Results for: FDA
The Food and Drug Administration (FDA) approved AstraZeneca's tremelimumab in combination with durvalumab and platinum-based chemotherapy for adult patients with...
GE Healthcare received FDA 510(k) clearance to add 3D imaging capabilities and PROPELLER technology as extensions to their AIR Recon...
Oxford Immunotec, a Perkin Elmer company, received FDA approval to use T-Cell Select with its in vitro diagnostics tuberculosis (TB)...
Another gene therapy product has been added to the FDA-approved list: SKYSONA, a one-time gene therapy aimed to treat early,...
One serious complication of chemotherapy is the reduced neutrophil count 7 to 12 days post-treatment. Severe neutropenia is characterized by...
Biliary tract cancer (BTC) is a form of gastrointestinal cancer that occurs in the bile duct, gallbladder, and ampulla of...
The FDA approved the Investigational New Drug application for initiating a Phase 1/2 clinical study of YH001 in combination with...
The FDA has granted breakthrough therapy designation to the ROS1 inhibitor taletrectinib for the treatment of patients with advanced or...
The FDA has granted approval for pemigatinib (Pemazyre) to treat adult patients with relapsed or refractory myeloid/lymphoid neoplasms (MLNs) and...